Literature DB >> 15671930

Endoscopic insertion of biliary stents in 18 patients with metallic duodenal stents who developed secondary malignant obstructive jaundice.

Geoffroy Vanbiervliet1, Jean-François Demarquay, Rémy Dumas, François-Xavier Caroli-Bosc, Thierry Piche, Albert Tran.   

Abstract

AIM: The aim of this work was to evaluate the feasibility of endoscopic insertion of biliary stents in patients with duodenal stents who develop secondary malignant obstructive jaundice. PATIENTS AND METHODS: The study population included 133 patients with unresectable malignant duodenal obstruction. In 106 patients a biliary stent was inserted before or at the same time as the duodenal stent. Malignant biliary obstruction appeared secondarily in 18 patients; fifteen of these patients already had a biliary stent. We present our experience of biliary stent insertion in these 18 patients with metallic duodenal stents.
RESULTS: Biliary obstruction was successfully alleviated in 17 out of 18 patients (94%) without complication. Insertion of a new biliary stent failed in one patient because the mesh of the duodenal stent passed over the metallic biliary stent already in place. Mean duration of endoscopic insertion was 95 minutes (range: 60 - 180). All patients remained free of biliary complications to death (57 days, range: 30 - 120).
CONCLUSION: Our report shows that endoscopic insertion of a biliary stent is feasible in patients who have metallic duodenal stents. Technical difficulties exist especially if the mesh of the duodenal stent passes over the papilla.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15671930     DOI: 10.1016/s0399-8320(04)95212-8

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  6 in total

1.  Endoscopic bilio-duodenal bypass: outcomes of primary and revision efficacy of combined metallic stents in malignant duodenal and biliary obstructions.

Authors:  Jorge Canena; João Coimbra; Diana Carvalho; Catarina Rodrigues; Mário Silva; Mariana Costa; David Horta; António Mateus Dias; Isabel Seves; Gonçalo Ramos; Leonel Ricardo; António Pereira Coutinho; Carlos Romão; Pedro Mota Veiga
Journal:  Dig Dis Sci       Date:  2014-05-13       Impact factor: 3.199

2.  Efficacy and Adverse Effects of Self-Expandable Metal Stent Placement for Malignant Duodenal Obstruction: The Papilla of Vater as a Landmark.

Authors:  Chi-Huan Wu; Mu-Hsien Lee; Yung-Kuan Tsou; Wei Teng; Cheng-Hui Lin; Kai-Feng Sung; Nai-Jen Liu
Journal:  Cancer Manag Res       Date:  2020-10-19       Impact factor: 3.989

Review 3.  Success and safety of endoscopic treatments for concomitant biliary and duodenal malignant stenosis: A review of the literature.

Authors:  Benedetto Mangiavillano; Mouen A Khashab; Ilaria Tarantino; Silvia Carrara; Rossella Semeraro; Francesco Auriemma; Mario Bianchetti; Leonardo Henry Eusebi; Chen Yen-I; Luca De Luca; Mario Traina; Alessandro Repici
Journal:  World J Gastrointest Surg       Date:  2019-02-27

Review 4.  Endoscopic ultrasound-guided double stenting for biliary and duodenal obstruction.

Authors:  Takao Itoi; Fumihide Itokawa; Atsushi Sofuni; Toshio Kurihara; Kentaro Ishii; Shujiro Tsuji; Nobuhito Ikeuchi; Junko Umeda; Rena Tanaka; Ryosuke Tonozuka; Fuminori Moriyasu
Journal:  Endosc Ultrasound       Date:  2012-04       Impact factor: 5.628

5.  Double Stenting for Malignant Biliary and Duodenal Obstruction: A Systematic Review and Meta-Analysis.

Authors:  Anna Fábián; Renáta Bor; Noémi Gede; Péter Bacsur; Dániel Pécsi; Péter Hegyi; Barbara Tóth; Zsolt Szakács; Áron Vincze; István Ruzsics; Zoltán Rakonczay; Bálint Erőss; Róbert Sepp; Zoltán Szepes
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

6.  The Dramatic Haemostatic Effect of Covered Self-expandable Metallic Stents for Duodenal and Biliary Bleeding.

Authors:  Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Ryoichiro Kobashi; Takuto Hikichi; Hiromasa Ohira
Journal:  Intern Med       Date:  2020-10-21       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.